I 

115TH CONGRESS 

1ST SESSION H. R. 1895 

To amend the Public Health Service Act to prohibit the Secretary of Health 

and Human Services from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, 

and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 4, 2017 

Mr. LUETKEMEYER (for himself, Mrs. HARTZLER, Mr. GRAVES of Missouri, 

Mr. BANKS of Indiana, Mr. BIGGS, Mr. MOONEY of West Virginia, Mr. 

FORTENBERRY, Mr. HARRIS, Mr. ABRAHAM, Mr. PITTENGER, Mr. LONG, 

Mr. GIBBS, Mr. ARRINGTON, Mr. JONES, Mr. FRANKS of Arizona, Mr. 

WEBSTER of Florida, and Mrs. WAGNER) introduced the following bill; 

which was referred to the Committee on Energy and Commerce 

A BILL 

To amend the Public Health Service Act to prohibit the 

Secretary of Health and Human Services from conducting or supporting any research involving human fetal 

tissue that is obtained pursuant to an induced abortion, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Protecting Life and 

5 Integrity in Research Act of 2017’’. 


lotter on DSK5VPTVN1PROD with BILLS
2 

•HR 1895 IH

1 SEC. 2. NO RESEARCH BY HHS INVOLVING HUMAN FETAL 

2 TISSUE OBTAINED PURSUANT TO AN IN3 DUCED ABORTION. 

4 (a) IN GENERAL.—The Public Health Service Act is 

5 amended by inserting after section 498A of such Act (42 

6 U.S.C. 289g–1) the following: 

7 ‘‘SEC. 498A–1. NO RESEARCH INVOLVING HUMAN FETAL TIS8 SUE OBTAINED PURSUANT TO AN INDUCED 

9 ABORTION. 

10 ‘‘(a) IN GENERAL.—The Secretary may not conduct 

11 or support any research involving human fetal tissue that 

12 is obtained pursuant to an induced abortion. 

13 ‘‘(b) DEVELOPMENT OF NEW, ETHICAL CELL

14 LINES.—Subsection (a) does not limit the authority of the 

15 Secretary to develop or support the development of new, 

16 high-efficiency cell lines, including for the production of 

17 vaccines and genetic vectors, so long as the cell lines are 

18 not derived from human fetal tissue that is obtained pur19 suant to an induced abortion.’’. 

20 (b) CONFORMING AMENDMENTS.—Section 498A of 

21 the Public Health Service Act (42 U.S.C. 289g–1) is 

22 amended— 

23 (1) in subsections (a)(2), (c)(1)(B), and (g), by 

24 striking ‘‘or induced’’ each place it appears; and 

25 (2) in subsection (b)(2)— 

26 (A) by striking subparagraph (A); and 


lotter on DSK5VPTVN1PROD with BILLS
3 

•HR 1895 IH

1 (B) by redesignating subparagraphs (B) 

2 and (C) as (A) and (B), respectively. 

3 SEC. 3. PROHIBITION AGAINST SOLICITATION OR KNOWING 

4 ACQUISITION, RECEIPT, OR ACCEPTANCE OF 

5 A DONATION OF HUMAN FETAL TISSUE 

6 KNOWING THAT THE TISSUE WAS OBTAINED 

7 PURSUANT TO AN INDUCED ABORTION. 

8 (a) IN GENERAL.—Paragraph (1) of section 498B(c) 

9 of the Public Health Service Act (42 U.S.C. 289g–2(c)) 

10 is amended to read as follows: 

11 ‘‘(1) solicit or knowingly acquire, receive, or ac12 cept a donation (excluding any transfer for purposes 

13 of autopsy or burial) of human fetal tissue knowing 

14 that— 

15 ‘‘(A) a human pregnancy was deliberately 

16 initiated to provide such tissue; or 

17 ‘‘(B) the tissue was obtained pursuant to 

18 an induced abortion; or’’. 

19 (b) CONFORMING CHANGES.—Section 498B of the 

20 Public Health Service Act (42 U.S.C. 289g–2) is amend21 ed— 

22 (1) by striking subsection (b); 

23 (2) by redesignating subsections (c) through (e) 

24 as subsections (b) through (d), respectively; 


lotter on DSK5VPTVN1PROD with BILLS
4 

•HR 1895 IH

1 (3) in subsection (c), as redesignated by para2 graph (2)— 

3 (A) in paragraph (1), by striking ‘‘(a), (b), 

4 or (c)’’ and inserting ‘‘(a) or (b)’’; and 

5 (4) in paragraph (2), by striking ‘‘or (b)(3)’’; 

6 SEC. 4. AUTHORIZATION FOR HHS RESEARCH ON FETAL 

7 TISSUE AND CORRESPONDING REPORTING. 

8 Section 498A of the Public Health Service Act (42 

9 U.S.C. 289g–1) is amended— 

10 (1) in the section heading, by striking ‘‘RE11 SEARCH ON TRANSPLANTATION OF FETAL TISSUE’’ 

12 and inserting ‘‘RESEARCH ON FETAL TISSUE’’; 

13 (2) in subsection (a)— 

14 (A) by striking ‘‘research on the transplan15 tation of human fetal tissue for therapeutic 

16 purposes’’ and inserting ‘‘research on human 

17 fetal tissue’’; and 

18 (B) by adding at the end the following: 

19 ‘‘Notwithstanding any other provision of law, 

20 any research of the Department of Health and 

21 Human Services on human fetal tissue shall be 

22 conducted or supported in accordance with this 

23 section.’’; and 


lotter on DSK5VPTVN1PROD with BILLS
5 

•HR 1895 IH

1 (3) in subsection (b)(1)(B), by inserting ‘‘if the 

2 fetal tissue is intended for transplantation,’’ before 

3 ‘‘the donation is made’’. 

Æ 


lotter on DSK5VPTVN1PROD with BILLS